SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-345824
Filing Date
2013-08-26
Accepted
2013-08-26 06:06:10
Documents
10
Period of Report
2013-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d589297d8k.htm 8-K 45627
2 EX-2.1 d589297dex21.htm EX-2.1 515869
3 EX-10.1 d589297dex101.htm EX-10.1 150744
4 EX-10.2 d589297dex102.htm EX-10.2 694198
5 EX-99.1 d589297dex991.htm EX-99.1 75708
6 GRAPHIC g589297ex10_2pg01.jpg GRAPHIC 2754
7 GRAPHIC g589297ex10_2pg128.jpg GRAPHIC 1984
8 GRAPHIC g589297ex10_2pg129.jpg GRAPHIC 2267
9 GRAPHIC g589297ex10_2pg130.jpg GRAPHIC 3836
10 GRAPHIC g589297ex99_1logo.jpg GRAPHIC 31638
  Complete submission text file 0001193125-13-345824.txt   1542824
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 131059155
SIC: 2836 Biological Products, (No Diagnostic Substances)